Search

Your search keyword '"Bisoffi, A."' showing total 479 results

Search Constraints

Start Over You searched for: Author "Bisoffi, A." Remove constraint Author: "Bisoffi, A." Language undetermined Remove constraint Language: undetermined
479 results on '"Bisoffi, A."'

Search Results

2. Association of country income level with the characteristics and outcomes of critically ill patients hospitalized with acute kidney injury and COVID-19

3. Data from Breast Field Cancerization: Isolation and Comparison of Telomerase-Expressing Cells in Tumor and Tumor Adjacent, Histologically Normal Breast Tissue

4. Supplementary Figure 2 from Breast Field Cancerization: Isolation and Comparison of Telomerase-Expressing Cells in Tumor and Tumor Adjacent, Histologically Normal Breast Tissue

5. Supplementary Figure 1 from Breast Field Cancerization: Isolation and Comparison of Telomerase-Expressing Cells in Tumor and Tumor Adjacent, Histologically Normal Breast Tissue

6. Inguinal Hernia Containing the Uterus in the Pediatric Patient: A Systematic Review

7. Humoral Effect of SARS-CoV-2 mRNA vaccination with booster dose in solid tumor patients with different anticancer treatments

8. Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study

10. Monkeypox 2022 outbreak in non-endemic countries: Open questions relevant for public health, nonpharmacological intervention and literature review

11. The diagnosis of human and companion animal Strongyloides stercoralis infection: Challenges and solutions. A scoping review

12. Identification and characterization of epicuticular proteins of nematodes sharing motifs with cuticular proteins of arthropods

13. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy

14. Load Carriage affects Kinematics during Ingress and Egress on Simulated Travelators

15. New Insights on Acute and Chronic Schistosomiasis: Do We Need a Redefinition?

16. Data-based guarantees of set invariance properties

17. SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals

18. High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial

19. Prenatal exposure to maternal psychological distress and telomere length in childhood

20. STArS (STrain-Amplicon-Seq), a targeted nanopore sequencing workflow for SARS-CoV-2 diagnostics and genotyping

22. Additional file 2 of Different decay of antibody response and VOC sensitivity in na��ve and previously infected subjects at 15 weeks following vaccination with BNT162b2

23. Additional file 3 of Different decay of antibody response and VOC sensitivity in na��ve and previously infected subjects at 15 weeks following vaccination with BNT162b2

24. Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection

25. Molecular characterization of Schistosoma infections in African migrants: identification of a Schistosoma haematobium-bovis hybrid in bladder biopsies

26. Data-driven control via Petersen’s lemma

27. Full-orbit and drift calculations of fusion product losses due to explosive fishbones on JET

28. Diagnostic accuracy of a novel enzyme-linked immunoassay for the detection of IgG and IgG4 against Strongyloides stercoralis based on the recombinant antigens NIE/SsIR

29. Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine

30. Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine

31. Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine

32. A wall-aligned grid generator for non-linear simulations of MHD instabilities in tokamak plasmas

33. Community Epidemiology Approach to Parasitic Infection Screening in a Remote Community in Ecuador

34. Reset integral control for improved settling of PID-based motion systems with friction

35. Morbidity Associated with Chronic Strongyloides stercoralis Infection: A Systematic Review and Meta-Analysis

36. Laboratory Parameters after Treatment for Loa loa and Mansonella perstans: The Experience of a Single Referral Center for Tropical Diseases in a Non-Endemic Area

37. Efficacy of ivermectin to control Strongyloides stercoralis infection in sheltered dogs

38. Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis

39. Antibody response to BTN162b2 mRNA vaccination in naïve versus SARS-CoV-2 infected subjects with and without waning immunity

40. Direct Quantitation of SARS-CoV-2 Using Droplet Digital PCR in Suspected Samples With Very Low Viral Load

41. ACoRE: Accurate SARS-CoV-2 genome reconstruction for the characterization of intra-host and inter-host viral diversity in clinical samples and for the evaluation of re-infections

42. Prevalence of Strongyloidiasis in a Cohort of Migrants in Italy and Accuracy of a Novel ELISA Assay for

44. Additional file 2 of Longitudinal study based on a safety registry for malaria patients treated with artenimol–piperaquine in six European countries

45. StrongNet: An International Network to Improve Diagnostics and Access to Treatment for Strongyloidiasis Control

46. SARS-CoV-2 Vaccination Elicits Unconventional IgM Specific Responses in Naïve and Previously COVID19-Infected Individuals

47. High Dose Ivermectin for the Early Treatment of COVID-19 (COVIER Study): A Randomised, Double-Blind, Multicentre, Phase II, Dose-Finding, Proof of Concept Clinical Trial

48. Additional file 1 of Longitudinal study based on a safety registry for malaria patients treated with artenimol–piperaquine in six European countries

49. Additional file 5 of Longitudinal study based on a safety registry for malaria patients treated with artenimol–piperaquine in six European countries

Catalog

Books, media, physical & digital resources